Tier 3 · Filer Universe

Apimeds Pharmaceuticals US, Inc.

APUS · NYSE American · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$0.65
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001894525
Liquidity rank
#6211
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenueNot publishedNot publishedNo matching frame
Annual diluted EPS-0.552025-12-310001213900-26-051139
Quarterly revenueNot publishedNot publishedNo matching frame
Quarterly diluted EPS-2.262026-03-310001213900-26-061013

SEC EDGAR Frames batch generated 2026-07-16T23:27:27.036Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNYSE AmericanBMY · Tier 1 peerDHR · Tier 1 peerTMO · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames